WILLIAM M. MOORE - 13 Jun 2025 Form 4 Insider Report for IRIDEX CORP (IRIX)

Role
Director
Signature
/s/ Nilo De Castro, Attorney-in-fact for William Moore
Issuer symbol
IRIX
Transactions as of
13 Jun 2025
Transactions value $
$0
Form type
4
Filing time
24 Jun 2025, 20:17:04 UTC
Previous filing
13 Jun 2025
Next filing
19 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MOORE WILLIAM M Director 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW /s/ Nilo De Castro, Attorney-in-fact for William Moore 24 Jun 2025 0001217126

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRIX Common Stock (right to buy) Award $0 +53,000 $0 53,000 13 Jun 2025 Common Stock 53,000 $0.94 Direct F1, F2
transaction IRIX Common Stock (right to buy) Award $0 +15,000 $0 15,000 13 Jun 2025 Common Stock 15,000 $0.94 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3.
F2 All shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the Company's 2026 annual meeting of stockholders.
F3 The shares are subject to vesting according to the following schedule: 1/48 of the total number of shares subject to the option shall vest on July 13, 2025, and each month thereafter, such that the option shall be fully vested on the earlier of (i) the four-year anniversary of the grant date or (ii) the Company's 2029 annual meeting of stockholders.